1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ACADIA PHARMACEUTICALS INC
Acadia Pharmaceuticals Inc XNAS: ACAD

Acadia Pharmaceuticals Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer
about

Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuros...

Read More
22.57 0.92 (4.25%)
68.43% Gain from 52W Low
1.6M
XNAS Volume

XNAS 07 Nov, 2025 4:30 PM (EST)

Watchlist

Portfolio

Alert
Board Meeting
The next board meeting for Acadia Pharmaceuticals Inc is on 18 Nov 2025 for the purpose of Jefferies Global Healthcare Conference See details
Durability score
High Financial Strength
61.1 / 100
Valuation Score
Affordable Valuation
51.3 / 100
Momentum Score
Technically Moderately Bullish
63.6 / 100
Strong Performer These stock companies have strong financials and are affordably priced. They also score high in quality and technical aspects which makes them a favourite amongst investors. View Similar Embed DVM
Analyst Price Target
29
1Yr Price target upside is 28%
20 analysts

11

S

5

W

5

O

1

T

SWOT Analysis

Acadia Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..